Th1 cytokine endotype discriminates and predicts severe complications in COVID-19
John Libbey Eurotext - 2022
Toshifumi Hasegawa1, Takashi Hato2, Toshitsugu Okayama3, Kazuho Ikeo3, Yukio Miyamoto4, Niina Iwanaga4, Kazuhisa Suzuki5, Mari Yoshida6, Kazuto Yamashita4, Saya Yamashita7, Eiya Tamada4, Abdullah Khasawneh8, Faith Jessica Paran9, Rieko Oyama9, Toshio Naito9, Kenta Noda10, Yoko Tabe8
1Research and Development Division, Sysmex R&D Centre Europe GmbH, Falkenried 88 20251 Hamburg, Germany
2Division of Nephrology, Indiana University, 107 S Indiana Ave, Bloomington, USA
3Center for Information Biology, National Institute of Genetics, 1111 Yata, Mishima, Sizuoka, Japan
4Central Research Laboratories, Sysmex Corporation, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan
5System Technology Laboratories, Sysmex Corporation, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan
6Scientific Affairs, Sysmex Corporation, Division 1-3-2, Murotani, Nish Ward, Kobe, Japan
7Business Incubation Department, Sysmex Corporation, 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan
8Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo Ward, Tokyo, Japan
9Department of Research Support Utilizing Bioresource Bank, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo Ward, Tokyo, Japan
10Reagent Engineering Department, Sysmex Corporation 4-4-4, Takatsuka-dai, Nish Ward, Kobe, Japan